Ambuja Cements (AMBUJACEM) — Board Meeting

Ambuja Cements' board approved Q3 and 9M FY2026 unaudited results (ended December 31, 2025) with 9M PAT of ₹3,686.22 crores and EPS of ₹11.36. Key decisions: (1) Managing Director Ajay Kapur's superannuation effective January 31, 2026; (2) Two major amalgamation schemes—ACC Limited (effective January 1, 2026) and Orient Cement (effective May 1, 2025)—pending NCLT approval; (3) Recognition of ₹1,179.71 crores tax provision reversal and ₹222.80 crores West Bengal incentive exceptional charge; (4) ₹1,193.75 crores CCI cartelization penalties with Supreme Court hearing February 4, 2026.

📄 View Original Announcement (PDF)

📊 Stock Analysis — AMBUJACEM ✨ Ask AI About This

About Ambuja Cements Limited (AMBUJACEM)

Construction Materials · Cement & Cement Products · Listed on NSE

Market Cap: ₹1,07,215.34 Cr P/E: 23.3 ROE: 7.7% ROCE: 4.6%

View full AMBUJACEM stock details →

📡 Get AI alerts when AMBUJACEM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track AMBUJACEM — Free

💡 Ask AI about this filing

"How does this board meeting affect Ambuja Cements Limited's outlook?" "What did Ambuja Cements Limited announce on 30 January 2026?" "Is this positive or negative for AMBUJACEM?"

Ask AI Free →

📊 More AMBUJACEM filings

See all AMBUJACEM filings →

🔥 Also filed on 30 January 2026

TATASTEEL Tata Steel Limited Announcement RECLTD REC Limited Financial Results ULTRACEMCO UltraTech Cement Limited Financial Results VEDL Vedanta Limited Financial Results VEDL Vedanta Limited Annual Report WIPRO Wipro Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when AMBUJACEM files new disclosures

Track AMBUJACEM filings, board meetings, and corporate actions. Free email alerts at 5 PM.